Fundraising FoxAdAlta
1 known investors
Find your way into AdAlta
Sign up to see every warm intro you have to AdAlta
- Paths you didn't know you had: your email and LinkedIn already hold routes to the AdAlta team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
AdAlta is a clinical-stage biotechnology company developing cell and protein therapeutics for serious diseases, including cellular immunotherapies for solid cancers. It applies an "East to West" strategy combining Asian innovation in T cell therapy with Australia's clinical and manufacturing ecosystem, and has developed candidates using its proprietary i-body technology.
Investors · 1
Frequently asked questions
- What does AdAlta do?
- AdAlta is a clinical-stage biotechnology company developing cell and protein therapeutics for serious diseases, including cellular immunotherapies for solid cancers. It applies an "East to West" strategy combining Asian innovation in T cell therapy with Australia's clinical and manufacturing ecosystem, and has developed candidates using its proprietary i-body technology.
- Who are AdAlta's investors?
- AdAlta's investors include Yuuwa Capital.